Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilar Deals 2025
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Diversity
Helen Macpherson
Intranet
Kimberley Evans
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
Paul Johns
PipCast®
PTE
Trade Marks
Webinars

Rituximab Study Shows Promise for Managing AIBD

Feb 4, 2024

A study published in Medicina, on 4 February 2024, concluded that Rituximab represents an efficacious and well-tolerated therapeutic option for the management of Autoimmune Bullous Diseases (AIBD) and warrants consideration in cases of refractory AIBD.